financetom
Business
financetom
/
Business
/
US FDA grants full approval to AbbVie's ovarian cancer therapy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA grants full approval to AbbVie's ovarian cancer therapy
Mar 22, 2024 11:55 AM

March 22 (Reuters) - The U.S. Food and Drug

Administration (FDA) said on Friday it had granted traditional

approval for AbbVie's ( ABBV ) "guided missile" cancer therapy,

Elahere, for adult patients with a type of ovarian and related

cancers who have received one to three prior lines of treatment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved